A Multicenter Cross-sectional Study on Mental Health of Patients With Multiple Myeloma
NCT05620420 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 501
Last updated 2024-11-26
Summary
Multiple myeloma patients with normal ability of communication and understanding will be enrolled. DT, GAD-7, PHQ-15 and PSQI scales are designed to assess the mental health status of the patients. Demographic and disease data of patients will be collected as well. The main aim is to explore the factors affecting the mental health of myeloma patients.
Conditions
- Psychological Distress
- Insomnia
- Somatic Symptoms
Sponsors & Collaborators
-
RenJi Hospital
lead OTHER
Principal Investigators
-
Jian Hou · RenJi Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-08
- Primary Completion
- 2023-11-07
- Completion
- 2023-11-07
Countries
- China
Study Locations
More Related Trials
-
The Efficacy and Safety of Colchicine Combined With Conventional Therapy in Multiple Myeloma Patients
NCT05802992 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics
NCT04678089 ·Status: UNKNOWN
-
Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"
NCT04888039 ·Status: RECRUITING
-
Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma
NCT01249690 ·Status: UNKNOWN ·Phase: PHASE4
-
Modified Bortezomib-based Combination Therapy for Multiple Myeloma
NCT02559154 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.
NCT00405756 ·Status: COMPLETED ·Phase: PHASE3
-
Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not
NCT06463717 ·Status: RECRUITING
-
A Clinical Trial Evaluating the Safety Tolerability, Radiation Absorption Dose, Distribution, PET Imaging and Histological Expression of 68Ga-NOTA-SCH001 in Patients With Multiple Myeloma
NCT06925958 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Real-World Use of Selinexor, Daratumumab and Dexamethasone in Chinese Patients With Multiple Myeloma at First Relapse
NCT05559788 ·Status: UNKNOWN
-
Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies
NCT02997813 ·Status: COMPLETED
-
Helical Tomotherapy in Multiple Myeloma
NCT05970198 ·Status: RECRUITING ·Phase: NA
-
A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) With Triple Class Exposure
NCT05217082 ·Status: COMPLETED
-
Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation
NCT06324266 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma
NCT05918185 ·Status: COMPLETED
-
MYeloma Resistance And Clonal Evolution
NCT03807128 ·Status: RECRUITING
-
Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma
NCT02027220 ·Status: UNKNOWN ·Phase: PHASE2
-
Multiple Myeloma Minimal Residual Disease
NCT02627261 ·Status: COMPLETED
-
The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma
NCT03777306 ·Status: COMPLETED ·Phase: NA
-
A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)
NCT05001087 ·Status: RECRUITING
-
Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma
NCT03190525 ·Status: ACTIVE_NOT_RECRUITING
-
Tolerability and Efficacy of Modified VCD Regimens in Previously Untreated Multiple Myeloma.
NCT02086942 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma
NCT05050097 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
NCT05136807 ·Status: RECRUITING
-
Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib
NCT01060202 ·Status: COMPLETED
-
Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma
NCT00002653 ·Status: UNKNOWN ·Phase: PHASE3